HMVRX
Price
$16.89
Change
-$0.14 (-0.82%)
Updated
Jul 21 closing price
Net Assets
1.15B
JVMCX
Price
$27.10
Change
-$0.14 (-0.51%)
Updated
Jul 21 closing price
Net Assets
22.64B
Interact to see
Advertisement

HMVRX vs JVMCX

Header iconHMVRX vs JVMCX Comparison
Open Charts HMVRX vs JVMCXBanner chart's image
Hartford MidCap Value R3
Price$16.89
Change-$0.14 (-0.82%)
VolumeN/A
Net Assets1.15B
JHancock Disciplined Value Mid Cap C
Price$27.10
Change-$0.14 (-0.51%)
VolumeN/A
Net Assets22.64B
HMVRX vs JVMCX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
HMVRX vs. JVMCX commentary
Jul 23, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is HMVRX is a Hold and JVMCX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
JVMCX has more cash in the bank: 22.6B vs. HMVRX (1.15B). HMVRX pays higher dividends than JVMCX: HMVRX (0.31) vs JVMCX (0.00). HMVRX was incepted earlier than JVMCX: HMVRX (15 years) vs JVMCX (14 years). JVMCX (1.88) is less costly to investors than HMVRX (1.48). HMVRX is a more actively managed with annual turnover of: 132.00 vs. JVMCX (49.00). HMVRX has a lower initial minimum investment than JVMCX: HMVRX (0) vs JVMCX (1000). JVMCX annual gain was more profitable for investors over the last year : -1.13 vs. HMVRX (-6.11). JVMCX return over 5 years is better than : 48.31 vs. HMVRX (30.60).
HMVRXJVMCXHMVRX / JVMCX
Total Expense Ratio1.481.8779%
Annual Report Gross Expense Ratio1.481.8879%
Fund Existence15 years14 years-
Gain YTD1.3097.66817%
Front LoadN/AN/A-
Min. Initial Investment01000-
Min. Initial Investment IRAN/AN/A-
Net Assets1.15B22.6B5%
Annual Yield % from dividends0.310.00-
Returns for 1 year-6.11-1.13543%
Returns for 3 years0.4416.333%
Returns for 5 years30.6048.3163%
Returns for 10 years7.4236.2220%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
ALFVY43.910.24
+0.55%
Alfa-Laval AB
NNXPF2.110.01
+0.48%
Nanoxplore Inc.
AFLYY1.34N/A
N/A
Air France-KLM
CYYNF0.08N/A
N/A
Cynata Therapeutics Ltd.
HLRD417.00N/A
N/A
Hilliard Corp.